Disclosure Table
The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:
________________________________________________________________________________________________________
Offeree: Strongbridge Biopharma plc
Offer period commenced: 24 May 2021
$0.01 ordinary shares; ISIN: IE00BYZ5XL97; NSI: 67,828,952
Offeror: Xeris Pharmaceuticals, Inc.
$0.001 common stock; ISIN US98422L1070; NSI: 66,497,370
________________________________________________________________________________________________________
Offeree: UDG Healthcare plc
Offer period commenced: 12 May 2021
€0.05 ordinary shares; ISIN: IE0033024807; NSI: 251,974,223
Offeror: Nenelite Limited, a company controlled by Clayton, Dubilier & Rice, LLC
Disclosure of interests and dealings in the relevant securities of the above offeror is not required.
_______________________________________________________________________________________________________
Download the Disclosure Table in Other Formats
